Birmingham Tech Used to Help Produce a COVID-19 Vaccine

TriAltus Bioscience LLC’s protein purification technology — licensed by the University of Alabama in Birmingham — is being used to support research into a COVID-19 vaccine. TriAltus, based in Birmingham, developed its “ultra-high affinity CL7/lm7 system” to isolate and purify the Spike protein (S-protein) from the SARS-COV2 virus and bind it to ELISA plates. The…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox